A Dignass

424 total citations
9 papers, 299 citations indexed

About

A Dignass is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, A Dignass has authored 9 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 6 papers in Genetics and 4 papers in Surgery. Recurrent topics in A Dignass's work include Inflammatory Bowel Disease (6 papers), Microscopic Colitis (5 papers) and Intraperitoneal and Appendiceal Malignancies (2 papers). A Dignass is often cited by papers focused on Inflammatory Bowel Disease (6 papers), Microscopic Colitis (5 papers) and Intraperitoneal and Appendiceal Malignancies (2 papers). A Dignass collaborates with scholars based in Germany, United States and Belgium. A Dignass's co-authors include Stefan Lindgren, CS Probert, Ragnar Befrits, G. Midhagen, Philippe Marteau, Jürgen Rademaker, Jürgen M. Stein, Oliver Schröder, H Hartmann and Gerhard Rogler and has published in prestigious journals such as Gut, Journal of Crohn s and Colitis and Zeitschrift für Gastroenterologie.

In The Last Decade

A Dignass

9 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Dignass Germany 5 251 212 80 40 38 9 299
Paula Peixe Portugal 8 182 0.7× 158 0.7× 66 0.8× 10 0.3× 19 0.5× 16 254
B E Sands United States 10 274 1.1× 200 0.9× 90 1.1× 21 0.5× 33 0.9× 77 334
WJ Sandborn United States 10 234 0.9× 212 1.0× 107 1.3× 29 0.7× 11 0.3× 21 360
A. D’Arienzo Italy 6 276 1.1× 278 1.3× 119 1.5× 33 0.8× 13 0.3× 8 361
B Mesnard France 5 167 0.7× 142 0.7× 40 0.5× 8 0.2× 31 0.8× 7 232
Laurie B. Grossberg United States 8 194 0.8× 135 0.6× 67 0.8× 26 0.7× 7 0.2× 20 317
Catherine Dong France 7 143 0.6× 113 0.5× 92 1.1× 9 0.2× 12 0.3× 12 235
T Feichtenschlager Austria 6 106 0.4× 87 0.4× 41 0.5× 12 0.3× 88 2.3× 14 218
D. J. Buurman Netherlands 7 244 1.0× 157 0.7× 50 0.6× 27 0.7× 24 0.6× 8 338
Matthew C. Choy Australia 8 231 0.9× 168 0.8× 77 1.0× 18 0.5× 11 0.3× 22 312

Countries citing papers authored by A Dignass

Since Specialization
Citations

This map shows the geographic impact of A Dignass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Dignass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Dignass more than expected).

Fields of papers citing papers by A Dignass

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Dignass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Dignass. The network helps show where A Dignass may publish in the future.

Co-authorship network of co-authors of A Dignass

This figure shows the co-authorship network connecting the top 25 collaborators of A Dignass. A scholar is included among the top collaborators of A Dignass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Dignass. A Dignass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Colombel, J F, et al.. (2023). P609 Impact of prior biologic exposure on durability of recaptured response to ozanimod during the True North open-label extension study. Journal of Crohn s and Colitis. 17(Supplement_1). i738–i739. 1 indexed citations
2.
Dignass, A, Miguel Regueiro, J F Colombel, et al.. (2023). DOP43 Extended induction in the True North OLE study: ozanimod efficacy in biologic-naive and biologic-experienced patients. Journal of Crohn s and Colitis. 17(Supplement_1). i110–i111. 4 indexed citations
3.
Schreiber, S, Silvio Danese, A Dignass, et al.. (2023). P151 Assessing comprehensive remission for Ulcerative Colitis in clinical practice: International consensus recommendations. Journal of Crohn s and Colitis. 17(Supplement_1). i311–i312. 3 indexed citations
4.
Dignass, A, Miguel Regueiro, J F Colombel, et al.. (2023). P687 Durability of recaptured response to ozanimod during the True North open-label extension. Journal of Crohn s and Colitis. 17(Supplement_1). i817–i818. 1 indexed citations
5.
Schreiber, S, A Dignass, H Hartmann, et al.. (2015). Vedolizumab bei Colitis ulcerosa und Morbus Crohn: eine Standortbestimmung. Zeitschrift für Gastroenterologie. 53(6). 591–602. 7 indexed citations
6.
Hartmann, F, et al.. (2013). P380 Safety and efficacy of bolus administered ferric carboxymaltose (500 mg) in the treatment of iron deficiency anaemia in IBD patients. Journal of Crohn s and Colitis. 7. S162–S162. 4 indexed citations
9.
Schröder, Oliver, et al.. (2004). A Study for the Evaluation of Safety and Tolerability of Intravenous High-Dose Iron Sucrose in Patients with Iron Deficiency Anemia due to Gastrointestinal Bleeding. Zeitschrift für Gastroenterologie. 42(8). 663–667. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026